Because PHA induced the BIP and IRE1α in breast cancer cells (Figure 3), their inhibitors, such as HA15 [47] and KIRA6 [48], may be applied to understand how much this modulation is important in the PHA effects and support the hypothesis of other non-ER stress pathways involved. The gene discussed is ERN1; the disease is breast carcinoma.